Fir Tree Capital Management’s AEON Biopharma AEON Stock Holding History

Fir Tree Capital Management’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,778	Closed	-$2M	–	223
2023 Q2	$2M	Hold	2,778	–	–	0.19%	180
2023 Q1	$2.03M	Sell	2,778 -4,244	-60%	-$3.08M	0.16%	190
2022 Q4	$5.08M	Sell	7,022 -2	-0%	-$1.43K	0.26%	135
2022 Q3	$4.98M	Hold	7,024	–	–	0.17%	197
2022 Q2	$4.96M	Hold	7,024	–	–	0.15%	209
2022 Q1	$4.95M	Hold	7,024	–	–	0.14%	216
2021 Q4	$4.92M	Buy	7,024 +80	+1%	+$56.3K	0.13%	219
2021 Q3	$4.88M	Hold	6,944	–	–	0.16%	186
2021 Q2	$4.82M	Buy	+6,944	New	+$4.85M	0.18%	164

Other funds holding AEON

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fir Tree Capital Management's AEON Position: Q3 2023 in Review

Fir Tree Capital Management sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 2,778 shares — an estimated $2M sold.

Fir Tree Capital Management first reported a position in AEON in Q2 2021 and held it in 9 quarters. The position peaked at $5.08M in Q4 2022. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

Fir Tree Capital Management reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
Fir Tree Capital Management sold 2,778 AEON Biopharma shares in Q3 2023, an estimated $2M.
Fir Tree Capital Management first reported a position in AEON Biopharma in Q2 2021 and held it in 9 quarters.
Fir Tree Capital Management's AEON Biopharma position peaked at $5.08M in Q4 2022.
15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on Fir Tree Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.